Loading AMGN charts…
May we use analytics cookies to see how vpside is used, including anonymous session recordings? Accepting also loads the price chart, which sets its own cookies. Essential cookies are always on. Privacy
Loading AMGN comparable companies…
| AMGNAmgen Inc.(opens in a new tab) | $253.56B | $38.09B | +9.1% | 69.5% | 30.0% | 6.66× | 29.0× |
|---|---|---|---|---|---|---|---|
| GILDGilead Sciences, Inc.(opens in a new tab) | $213.86B | $30.99B | +6.5% | 79.9% | −7.6% | 6.90× | — |
| REGNRegeneron Pharmaceuticals, Inc.(opens in a new tab) | $97.96B | $16.90B | +18.6% | 96.5% | 28.8% | 5.80× | 20.5× |
| VRTXVertex Pharmaceuticals Inc. / Ma(opens in a new tab) | $142.67B | $12.59B | +10.2% | 86.0% | 38.0% | 11.33× | 32.6× |
| BIIBBiogen Inc.(opens in a new tab) | $37.48B | $10.30B | +2.3% | 74.0% | 22.9% | 3.64× | 109.3× |
| Medianpeers, excl. AMGN | $120.31B | $14.74B | +8.4% | 83.0% | 25.8% | 6.35× | 32.6× |